Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How to improve the diagnostic process.

A Eisen1

  • 1FRCPC, Neuromuscular Diseases Unit, Vancouver General Hospital, Canada. eisen@interchange.ubc.ca

Journal of Neurology
|January 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Breast cancer diagnosis and treatment wait times in specialized diagnostic units compared with usual care: a population-based study.

Current oncology (Toronto, Ont.)·2020
Same author

Baseline staging imaging for distant metastasis in women with stages I, II, and III breast cancer.

Current oncology (Toronto, Ont.)·2020
Same author

Cost-utility analysis of 21-gene assay for node-positive early breast cancer.

Current oncology (Toronto, Ont.)·2019
Same author

Impact of a novel prioritization framework on clinician-led oncology drug submissions.

Current oncology (Toronto, Ont.)·2019
Same author

Response to: The Survival Time of 8376 Male Breast Cancer Patients.

Clinical oncology (Royal College of Radiologists (Great Britain))·2018
Same journal

The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review.

Journal of neurology·2026
Same journal

Brain-first versus body-first Parkinson's disease: Differential findings on pupillary, brainstem and vagus sonography.

Journal of neurology·2026
Same journal

Spontaneous intracranial hypotension due to pelvic cerebrospinal fluid leak.

Journal of neurology·2026
Same journal

Morbidity and medication use preceding a diagnosis of late-onset Alzheimer's disease: a Danish nationwide study.

Journal of neurology·2026
Same journal

Comorbid autoimmune disease in stiff-person syndrome spectrum disorder: a systematic review and meta-analysis.

Journal of neurology·2026
Same journal

Tetrahydrocannabinol/cannabidiol in the treatment of restless legs syndrome.

Journal of neurology·2026
See all related articles

Early diagnosis of amyotrophic lateral sclerosis (ALS) is crucial but challenging due to limited awareness among primary care physicians and the general public. Improving diagnostic pathways and physician education is essential for timely intervention in this rare neurodegenerative disease.

Area of Science:

  • Neurology
  • Neurodegenerative Diseases
  • Diagnostic Medicine

Background:

  • Amyotrophic lateral sclerosis (ALS) is a rare, fatal neurodegenerative disorder with limited therapeutic options.
  • Early diagnosis is critical for effective management and potential therapeutic advancements.
  • Current diagnostic pathways are often delayed due to low awareness among healthcare professionals and the public.

Purpose of the Study:

  • To identify factors contributing to diagnostic delays in amyotrophic lateral sclerosis (ALS).
  • To propose improvements for the early diagnosis of ALS.
  • To highlight the need for increased awareness of ALS among medical professionals and the general population.

Main Methods:

  • Review of the current three-step diagnostic process for ALS in many countries.

Related Experiment Videos

  • Analysis of factors contributing to low awareness and diagnostic delays.
  • Discussion of potential improvements to the diagnostic pathway.

    • Main Results:

    • The multi-step diagnostic process for ALS is cumbersome and leads to delays.
    • Limited exposure to ALS cases results in low awareness among family physicians and community neurologists.
    • Lack of a definitive biological marker further complicates early diagnosis.

    Conclusions:

    • Improving physician and public awareness of ALS is urgently needed.
    • Streamlining the diagnostic process and potentially incorporating biological markers can enhance early detection.
    • Enhanced education and awareness initiatives are vital for improving outcomes for patients with amyotrophic lateral sclerosis.